Figure 4.
miR-217 expression promotes left ventricular dysfunction. A, Left ventricular diastolic function assessed as the ratio of Doppler-detected peak early diastolic velocity (E′) to peak late diastolic velocity (A′) in control apoE−/− mice (miR-217+/+ VE-Cad CreERT2TG/+ apoE−/−) and miR-217KI apoE−/− mice (miR-217KI/+ VE-Cad CreERT2TG/+ apoE−/−) fed an HFD for 8 wk. Right, Representative echocardiography images. B, D2 pulmonary vein velocity in control apoE−/− and miR-217KI apoE−/− mice fed an HFD for 8 wk. C, Left ventricular ejection fraction in control apoE−/− and miR-217KI apoE−/− mice determined by echocardiography after 10 wk on an HFD. Data are from 2 independent experiments. Each dot represents an individual mouse. *P<0.05, **P<0.01 by unpaired t test (A–C). apoE indicates apolipoprotein E; LVID;d, left ventricular internal diameter in diastole; and LVID;s, left ventricular internal diameter in systole.